Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants.

Trial Profile

Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2013

At a glance

  • Drugs Enterovirus A vaccine (Primary) ; Aluminium hydroxide
  • Indications Coxsackievirus infections; Enterovirus A infections
  • Focus Pharmacodynamics
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 10 Jan 2012 Status changed from active, no longer recruiting to completed, according to a Sinovac Biotech media release.
    • 09 Nov 2011 Interim results published in a Sinovac Biotech media release.
    • 09 Nov 2011 Status changed from recruiting to active, no longer recruiting, according to a Sinovac Biotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top